Does RISANKIZUMAB-RZAA Cause Therapy interrupted? 164 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 164 reports of Therapy interrupted have been filed in association with RISANKIZUMAB-RZAA. This represents 0.3% of all adverse event reports for RISANKIZUMAB-RZAA.
164
Reports of Therapy interrupted with RISANKIZUMAB-RZAA
0.3%
of all RISANKIZUMAB-RZAA reports
0
Deaths
32
Hospitalizations
How Dangerous Is Therapy interrupted From RISANKIZUMAB-RZAA?
Of the 164 reports, 32 (19.5%) required hospitalization, and 1 (0.6%) were considered life-threatening.
Is Therapy interrupted Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 164 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Therapy interrupted?
ADALIMUMAB (5,755)
ETANERCEPT (3,397)
RELUGOLIX (3,251)
CERTOLIZUMAB PEGOL (3,209)
LENALIDOMIDE (2,724)
UPADACITINIB (1,741)
ABATACEPT (1,726)
CLOZAPINE (1,722)
AMIKACIN (1,283)
TOFACITINIB (1,182)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Therapy interrupted Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA